Cumberland Pharmaceuticals Inc.
CPIX
$4.35
-$1.01-18.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 164.59% | 69.75% | -47.16% | -224.47% | -1,112.64% |
| Total Depreciation and Amortization | -8.29% | 31.13% | -5.76% | -4.84% | 0.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.35% | -112.96% | -1.42% | -107.48% | 88.73% |
| Change in Net Operating Assets | 180.96% | -16.33% | -11.36% | -189.04% | -44.01% |
| Cash from Operations | 282.46% | 83.12% | -61.54% | -116.34% | -50.66% |
| Capital Expenditure | -14.42% | 95.28% | 71.00% | 90.03% | 61.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,012.05% | -107.92% | 589.26% | -60.98% | 75.30% |
| Cash from Investing | -2,010.31% | -110.28% | 299.37% | 51.65% | 66.65% |
| Total Debt Issued | -- | -28.57% | 41.34% | 37.50% | 37.50% |
| Total Debt Repaid | -30.33% | 19.44% | -37.36% | -0.63% | 5.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.69% | 47.94% | 51.02% | 17.57% | -32.34% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.96% | 59.92% | 3.93% | 3.13% | 56.93% |
| Cash from Financing | -328.19% | 7.31% | 39.18% | 90.55% | 236.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,358.62% | 368.06% | -50.44% | -165.06% | 106.73% |